HEALTH/CANCER: Provides with respect to the advisory board created to recommend new treatments for rare cancers (EN NO IMPACT See Note)

The deadline for submitting written reports to the legislature was extended from 30 days to 45 days after each meeting.

The requirement for quarterly public meetings was simplified by removing the exception clause that allowed meetings to be skipped via a vote or chairperson order.

The board composition was revised to remove specific representatives from the Louisiana Cancer Association and the Louisiana Association of Health Plans.

The number of oncologists required on the advisory board was increased to improve medical oversight of rare cancer treatments.

Added official signatures and titles for the Speaker of the House, President of the Senate, and Governor, converting the bill from a draft to the final enrolled version.

Updated page numbering from 'Page 1 of 3' to 'Page 1 of 2' and removed the House Legislative Services digest, which is informational and not part of the law.

Removed the 'REENGROSSED' header and replaced it with 'ENROLLED' to indicate the bill has passed all legislative stages.

Added a specific effective date clause stating the act becomes effective upon the governor's signature or if vetoed, upon legislative approval.

Extended the deadline for the advisory board to submit written reports to the legislature from 30 days to 45 days after each meeting.

Changed the entity responsible for the chairperson of the advisory board from the Louisiana Cancer Research Center to the Cancer Association of Louisiana.

Added multiple new sponsors to the bill, expanding the list of representatives supporting the legislation.